SINGER DAVID B sold $28.9M of INFQ (indirect holdings)
SINGER DAVID B sold 1,797,637 indirectly-held shares of Infleqtion, Inc. (INFQ) at an average of $16.10 ($16.05–$17.91, $28.94M total) across 6 trades on 2026-05-29.
How this was made
The 30-second read
Why it matters
A director's complete exit is a material event that can affect stock perception.
Market read
The filing provides fresh, material information that traders may consider for short-term positioning.
What to watch
Potential upcoming financing needs or personal tax planning for the director.
Background
SEC Form 4 filing discloses insider transactions for public companies.
Ticker impact
Director David B. Singer sold all 1,797,637 shares for $28.9M, reducing his stake to zero.
likely pressure as the market prices in the director's exit
A director exiting with a $28.9M sale is material and often interpreted as a lack of confidence.
Market effects
May raise concerns for the biotech sector about insider confidence.
Limited to US biotech investors.
Minimal global impact beyond INFQ shareholders.
Counterpoint
The sale could be a routine liquidity move unrelated to company fundamentals.
Key entities
- CompanyInfleqtion, Inc.
Biotech company listed on NASDAQ under ticker INFQ.
- IndividualDavid B. Singer
Director of Infleqtion who sold his entire stake.
